Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Monster Beverage

We believe that the beverage company – Monster Beverage (NASDAQ: MNST) is currently a better pick over the robotic surgical platform maker Intuitive Surgical stock (NASDAQ: ISRG). The decision to invest often comes down to finding the best stocks within the scope of certain characteristics that suit an investment style.

After A 15% Fall This Year Is Monster Beverage A Better Pick Over Intuitive Surgical Stock?

Serve Robotics Inc

Tesla

The growth of artificial intelligence is a rising tide that raises all ships. This is evident when looking at one-year growth of companies such as Microsoft (NASDAQ: MSFT ), Meta Platforms (NASDAQ: META ) and Nvidia (NASDAQ: NVDA ), through a historic AI bull run that we are still in.

The 3 Smartest Robotics Stocks to Buy With $500 Right Now

Intuitive Surgical (ISRG) is making strides in the robotic-assisted surgery market with its existing and new launches. However, macro challenges are likely to continue to hurt its performance.

Intuitive Surgical (ISRG) Rises 10% in a Month: What's Next?

Creo Medical Group PLC (AIM:CREO) and Intuitive Surgical Inc (NASDAQ:ISRG, ETR:IUI1) have expanded their collaboration to enhance lung cancer treatments across the UK and Europe. This initiative broadens the scope of an agreement that combines diagnostics and treatment in a single procedure using advanced medical technology.

Creo Medical accelerates collaboration with US robotic surgery group

iRobot

Symbotic Inc

There are multiple signs that robots are already being used on a very wide scale and will soon proliferate throughout society. For example, Tesla (NASDAQ: TSLA ) recently reported that it had begun successfully using two of its humanoid, artificial intelligence-powered autonomous robots in one of its factories.

The 3 Best Robotics Stocks to Buy in July 2024

Eli Lilly

These profitable businesses are leaders in their respective healthcare sectors. Intuitive Surgical is the global market leader in surgical robotics, with a sneaky recurring revenue model.

2 Top Healthcare Stocks to Buy in June

Intuitive Surgical is capturing strong demand for its lineup of robotic surgical systems. Analysts anticipate new artificial intelligence and machine learning features to drive growth.

Intuitive Surgical Stock: Buy, Sell, or Hold?

The latest trading day saw Intuitive Surgical, Inc. (ISRG) settling at $442.56, representing a +0.06% change from its previous close.

Intuitive Surgical, Inc. (ISRG) Rises But Trails Market: What Investors Should Know

Investors are optimistic about Intuitive Surgical's (ISRG) strength in robotics.

Intuitive Surgical (ISRG) Hits 52-Week High: What's Aiding It?

Amazon

Baidu

Alphabet

Confession Time: I Own 5 Industry-Leading Artificial Intelligence (AI) Stocks, but Not for the Reason You Might Think

Transmedics Group Inc

United Therapeutics

Medical devices are spearheading the digitalization of healthcare, reports analytics and software development company Luxoft. Specifically, medical devices are “providing accurate diagnoses, effective treatments and personalized care through advanced algorithms and patient data analysis.

The 3 Best Medical Device Stocks to Buy in June 2024

Kenvue

Medtronic

Healthcare stocks offer a haven for investors amidst the uncertainty. The Fed elected to hold interest rates at a 23-year high between 5.25% and 5.5% to combat persistent inflation.

3 Healthcare Stocks to Buy Now: June 2024

Advanced Micro Devices

New Linde PLC

MercadoLibre

Novo Nordisk

Southern Company

Toyota Motor

Earnings are exactly what they sound like. They're everything that's left over after everything else has been paid.

7 Stocks With Impressive Earnings Growth: Real or Engineered?

Cadence Design Systems

Zero or low-debt stocks have gained popularity recently as they avoid additional financial costs associated with debt servicing. Companies without interest payments on loans have more funds to return to shareholders, potentially leading to higher stock prices.

3 Low-Debt Stocks Delivering High Returns

Honeywell

Mobileye Global Inc

Rockwell Automation

Stryker

Automation stocks can be a tricky subject fundamentally speaking. With advances in artificial intelligence combined with enhanced connectivity – as in the Internet of Things or IoT – machines can end up taking over human jobs.

7 Automation Stocks to Propel Your Portfolio to Profits

Intuitive Surgical, Inc. (ISRG) provides specialized robotic surgery equipment that is growing in use and capabilities.

Intuitive Surgical Ready for More Growth

Aurora Innovation

Cognex

Teradyne

Zebra Technologies

As the broader indices like the Nasdaq continue their upward trajectory, now is a compelling time to consider investing in robotics stocks. The robotics industry, buoyed by rapid technological advancements and increasing demand across sectors such as manufacturing, logistics and healthcare, presents a wealth of opportunities for savvy investors looking for the best robotics stocks to buy.

The 7 Best Robotics Stocks to Buy in June 2024

ABB Ltd

My task today is to identify three robotics stocks to buy in June that you can turn into $1 million from a $1,000 investment.  As I write this mid-way through June, the S&P 500 is already up nearly 15% on the year, while the largest U.S.-listed robotics exchange-traded fund, the Global X Robotics & Artificial Intelligence (NASDAQ: BOTZ ) with $2.75 billion in net assets, is up 43 basis points year-to-date relative to the index.

3 Robotics Stocks to Turn $1000 into $1 Million: June 2024

In the most recent trading session, Intuitive Surgical, Inc. (ISRG) closed at $422.90, indicating a -1.21% shift from the previous trading day.

Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: Here's Why

Intuitive Surgical can make for a good investment whether you're bullish on healthcare or artificial intelligence. The company recently launched its latest surgical system, which can benefit from advancements in AI.

Forget Nvidia, Buy This Magnificent Growth Stock Instead

Intuitive Surgical, Inc. is well-poised for growth in the coming quarters, courtesy of its strength in robotics. The optimism, led by solid results in the last few quarters and its progress on the Artificial Intelligence front, is expected to contribute further. However, procedure adoption risks and stiff competition persist.

Reasons to Retain Intuitive Surgical in Your Portfolio

Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Intuitive Surgical Inc (ISRG) - Product Pipeline Analysis, 2024 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Report Scope:

Intuitive Surgical (ISRG) Company Profile - 2024 Product Pipeline Analysis and Ongoing Clinical Trials Insights

Intuitive Surgical (ISRG) continues to raise optimism among investors owing to its strength in robotics.

Reasons to Retain Intuitive Surgical (ISRG) in Your Portfolio

Microsoft

Growth stocks are those that grow faster than average as measured at the top line or by revenue. If we measure growth across the S&P 500, it stands somewhere around 4% on average.

The Tortoise and the Hare: 3 Growth Stocks for Slow and Steady Wins

Intuitive Surgical (ISRG) announces the FDA clearance of revised da Vinci Xi and X Labeling on Radical Prostatectomy.

News for Intuitive Surgical Stock (ISRG)